Loading clinical trials...
Loading clinical trials...
The main purpose of this study was to investigate the effectiveness of cladribine tablets in a UK real-world setting.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Collaborators
NCT05758831 · Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis
NCT06586177 · Relapsing-remitting Multiple Sclerosis
NCT05906992 · Relapsing-remitting Multiple Sclerosis
NCT05755061 · Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis
NCT07517185 · Relapsing-remitting Multiple Sclerosis
University Hospitals Coventry and Warwickshire- Neurology
Coventry
NHS Lanarkshire Health Board- Department of Neurology
Glasgow
Queen Elizabeth University Hospital
Glasgow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions